Tenoxicam
Tenoxicam is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pain Control During ESWL Using Non-Opioid Analgesics
Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management
Effects on Recovery of Postoperative Gastrointestinal Function With Multimodal Analgesia
Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam
Tenoxicam for Intrapartum Analgesia
Clinical Trials (7)
Pain Control During ESWL Using Non-Opioid Analgesics
Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management
Effects on Recovery of Postoperative Gastrointestinal Function With Multimodal Analgesia
Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam
Tenoxicam for Intrapartum Analgesia
Efficacy of Intravenous Dexketoprofen and Tenoxicam on Propofol Associated Injection Pain
Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7